Evolus (EOLS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Voting matters and shareholder proposals
Election of two Class II directors, Brady Stewart and Vikram Malik, for a three-year term is up for vote.
Ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026 is proposed.
Advisory approval of named executive officer compensation is included as a voting item.
Shareholders may address other business that may properly come before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and auditor ratification.
Executive compensation and say-on-pay
Advisory vote on executive compensation for named executive officers is scheduled.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Evolus
- All proposals were approved with no shareholder questions during the virtual meeting.EOLS
AGM 202611 Jun 2026 - Shelf registration allows up to $250M in securities offerings for the cash-pay aesthetic market.EOLS
Registration filing5 Jun 2026 - Diversified aesthetics portfolio, digital scale, and innovation drive growth and profitability.EOLS
Jefferies Global Healthcare Conference 20264 Jun 2026 - Q1 2026 saw 7% revenue growth, positive Adjusted EBITDA, and reaffirmed full-year guidance.EOLS
Q1 202611 May 2026 - Portfolio expansion, market recovery, and loyalty programs drive strong growth outlook.EOLS
Leerink Global Healthcare Conference 20266 May 2026 - Double-digit growth and digital innovation drive sustained profitability and market expansion.EOLS
Investor presentation4 May 2026 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance.EOLS
Proxy filing29 Apr 2026 - Double-digit growth, expanding HA portfolio, and Sculpt approval set the stage for 2026-2028.EOLS
25th Annual Needham Virtual Healthcare Conference14 Apr 2026 - Low-cost, quality-driven cannabis operator targets rapid, profitable multi-state growth.EOLS
Investor presentation10 Apr 2026